Reduced prostacyclin activity in systemic lupus erythematosus

scientific article

Reduced prostacyclin activity in systemic lupus erythematosus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/ARD.39.5.524
P932PMC publication ID1000597
P698PubMed publication ID7002067
P5875ResearchGate publication ID16197107

P2093author name stringMcVerry BA
Machin SJ
Goldstone AH
Parry H
P2860cites workAn enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationQ28244623
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?Q33492455
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregationQ39412962
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendotheliumQ40989621
Thrombosis of Renal Veins and Inferior Vena Cava Complicating Lupus NephritisQ72146110
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)524-525
P577publication date1980-10-01
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titleReduced prostacyclin activity in systemic lupus erythematosus
P478volume39

Reverse relations

cites work (P2860)
Q72452321"Lupus" and prostacyclin formation
Q72498945Antiphospholipid antibodies and thrombosis
Q72451284Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation
Q33554309Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus erythematosus and lupus anticoagulant
Q33379907Immunology and Clinical Importance of Antiphospholipid Antibodies
Q71914828Lupus anticoagulant in patients with peripheral vascular disease: a prospective study
Q72565195Lupus anticoagulant, recurrent abortion, and prostacyclin production by cultured smooth muscle cells
Q41123263Lupus anticoagulant: interference with in vivo prostaglandin production and with platelet sensitivity to prostacyclin
Q86527461Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant
Q43423345Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody
Q70454668Pulmonary hypertension in systemic lupus erythematosus
Q37022415Stroke as an early manifestation of systemic lupus erythematosus
Q33393937The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.
Q33555478The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension
Q69948676The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension
Q33478061Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant
Q72452313Unlimited suckling time improves breast feeding
Q70608622[Antiprothrombinase antibodies and surgery]
Q69983908[Circulating anticoagulants. Clinical conditions of diagnosis]

Search more.